Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics.
Saved in:
| Title: | Toxicologic Pathology Forum: Considerations Regarding Determination of Adversity for Immunopathology Findings in Nonclinical Toxicology Studies with Immune-Modulating Therapeutics. |
|---|---|
| Authors: | Papenfuss TL; StageBio, Mount Jackson, Virginia, USA., Himmel L; AbbVie Inc., North Chicago, Illinois, USA., Kuper CF; Independent Consultant, Utrecht, The Netherlands., Mohanan S; Gilead Sciences, Foster City, California, USA., Harleman J; Independent Consultant, Darmstadt, Germany., Elmore SA; ElmorePathology LLC, Chapel Hill, North Carolina, USA. |
| Source: | Toxicologic pathology [Toxicol Pathol] 2023 Jun; Vol. 51 (4), pp. 205-215. Date of Electronic Publication: 2023 Aug 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Publications Country of Publication: United States NLM ID: 7905907 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-1601 (Electronic) Linking ISSN: 01926233 NLM ISO Abbreviation: Toxicol Pathol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1533-1601 |
|---|---|
| DOI: | 10.1177/01926233231190382 |
